BRCA1 and fallopian tube cancer: Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 or BRCA2 mutation carriers indicated that RRSO was associated with a statistically significant reduction in the risk of BRCA1/2-associated ovarian or fallopian tube cancer (HR 0.21) [181].